Should I buy or sell West Pharmaceutical Services stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" WST shares. View WST analyst ratings or view top-rated stocks .

What is West Pharmaceutical Services' stock price target for 2024?

5 Wall Street analysts have issued 1 year price objectives for West Pharmaceutical Services' shares. Their WST share price targets range from $375.00 to $536.00. On average, they anticipate the company's share price to reach $435.20 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price. View analysts price targets for WST or view top-rated stocks among Wall Street analysts .

How have WST shares performed in 2024?

West Pharmaceutical Services' stock was trading at $352.12 on January 1st, 2024. Since then, WST shares have increased by 4.6% and is now trading at $368.18. View the best growth stocks for 2024 here .

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) posted its quarterly earnings data on Thursday, February, 15th. The medical instruments supplier reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.05. The medical instruments supplier earned $732 million during the quarter, compared to analyst estimates of $740.43 million. West Pharmaceutical Services had a net margin of 20.12% and a trailing twelve-month return on equity of 21.60%. West Pharmaceutical Services's revenue was up 3.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.77 earnings per share. Read the conference call transcript .

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Tuesday, February 20th. Shareholders of record on Wednesday, April 24th will be given a dividend of $0.20 per share on Wednesday, May 1st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.22%. The ex-dividend date is Tuesday, April 23rd. Read our dividend analysis for WST .

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.21%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 10.15%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 8.77% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for WST .

What ETFs hold West Pharmaceutical Services' stock?

ETFs with the largest weight of West Pharmaceutical Services (NYSE:WST) stock in their portfolio include Subversive Mental Health ETF (SANE) , Formidable Fortress ETF (KONG) , VictoryShares THB Mid Cap ESG ETF (MDCP) , Nuveen ESG Mid-Cap Growth ETF (NUMG) , BlackRock Future Health ETF (BMED) , Tema Cardiovascular and Metabolics ETF (HRTS) , BlackRock Future Innovators ETF (BFTR) and Hilton Small-MidCap Opportunity ETF (SMCO) .

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY 2024 earnings guidance on Thursday, April, 25th. The company provided EPS guidance of 7.630-7.880 for the period, compared to the consensus EPS estimate of 7.620. The company issued revenue guidance of $3.0 billion-$3.0 billion, compared to the consensus revenue estimate of $3.0 billion.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com . Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA) , Johnson & Johnson (JNJ) , AbbVie (ABBV) , Walt Disney (DIS) , Home Depot (HD) , Visa (V) , Alibaba Group (BABA) , McDonald's (MCD) , Netflix (NFLX) and PepsiCo (PEP) .

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by many different institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (4.50%), Congress Asset Management Co. MA (0.45%), Sumitomo Mitsui Trust Holdings Inc. (0.26%), AMI Asset Management Corp (0.23%), New York State Teachers Retirement System (0.11%) and Raymond James & Associates (0.10%). Insiders that own company stock include Annette F Favorite , Bernard Birkett , Chad Winters , Charles Witherspoon, Cindy Reiss-Clark , Eric Mark Green , Quintin J Lai , Silji Abraham and Thomas W Hofmann . View institutional ownership trends .

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does West Pharmaceutical Services have any subsidiaries?

The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc.. Read More

NYSE:WST

West Pharmaceutical Services (WST) Stock Price, News & Analysis

→ It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad)

Free WST Stock Alerts

$368.18

-17.55 (-4.55%)

(As of 04/25/2024 ET)

Compare

Today's Range: $364.89
▼
$390.33
50-Day Range: $350.18
▼
$399.39
52-Week Range: $310.42
▼
$415.73

Volume: 742,360 shs
Average Volume: 515,105 shs
Market Capitalization: $26.95 billion

P/E Ratio: 46.72
Dividend Yield: 0.22%
Price Target: $435.20

Get West Pharmaceutical Services alerts:

West Pharmaceutical Services MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.80 Rating Score
Upside/Downside: 18.2% Upside
$435.20 Price Target
Short Interest: Healthy
1.34% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -2.53
Upright™ Environmental Score
News Sentiment: 0.85
Based on 18 Articles This Week
Insider Trading: Selling Shares
$26.65 M Sold Last Quarter
Proj. Earnings Growth: 19.69%
From $7.62 to $9.12 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.85 out of 5 stars

Medical Sector

38th out of 908 stocks

Surgical & Medical Instruments Industry

8th out of 96 stocks

2.4

Analyst's Opinion

Consensus Rating
West Pharmaceutical Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
West Pharmaceutical Services has only been the subject of 3 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
1.34% of the float of West Pharmaceutical Services has been sold short.
Short Interest Ratio / Days to Cover
West Pharmaceutical Services has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in West Pharmaceutical Services has recently decreased by 13.64%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
West Pharmaceutical Services has a dividend yield of 0.21%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
West Pharmaceutical Services has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of West Pharmaceutical Services is 10.15%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 8.77% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.

3.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
West Pharmaceutical Services has received a 33.75% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Plastic medicine bottles", "Plastic medicine vials", and "Pen needles" products. See details.
Environmental Sustainability
The Environmental Impact score for West Pharmaceutical Services is -2.53.

3.2

News and Social Media Coverage

News Sentiment
West Pharmaceutical Services has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 18 news articles for West Pharmaceutical Services this week, compared to 6 articles on an average week.
Search Interest
2 people have searched for WST on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added West Pharmaceutical Services to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, West Pharmaceutical Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $26,653,772.00 in company stock.
Percentage Held by Insiders
Only 0.53% of the stock of West Pharmaceutical Services is held by insiders.
Percentage Held by Institutions
93.90% of the stock of West Pharmaceutical Services is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for West Pharmaceutical Services are expected to grow by 19.69% in the coming year, from $7.62 to $9.12 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of West Pharmaceutical Services is 46.72, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.07.
Price to Earnings Ratio vs. Sector
The P/E ratio of West Pharmaceutical Services is 46.72, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 256.23.
Price to Earnings Growth Ratio
West Pharmaceutical Services has a PEG Ratio of 6.67. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
West Pharmaceutical Services has a P/B Ratio of 9.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Tranzact

What is Medicare Supplement Insurance?

Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.

Learn More Here

About West Pharmaceutical Services Stock (NYSE:WST)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

WST Stock Price History

30 days | 90 days | 365 days | Advanced Chart

WST Stock News Headlines

April 25, 2024 | finanznachrichten.de

West Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend

April 25, 2024 | gurufocus.com

West Pharmaceutical Services Inc. (WST) Q1 2024 Earnings: Adjusted EPS Rises Amidst Sales Decline

April 26, 2024 | WealthPress (Ad)

$25,000 into $109,616 in two months?

Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…

April 25, 2024 | reuters.com

West Pharma posts beat-and-raise quarter aided by strong demand for injectables

April 25, 2024 | prnewswire.com

West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend

April 22, 2024 | americanbankingnews.com

West Pharmaceutical Services, Inc. Plans Quarterly Dividend of $0.20 (NYSE:WST)

April 19, 2024 | forbes.com

Ex-Dividend Reminder: Lennar, Lowe’s And West Pharmaceutical

April 18, 2024 | markets.businessinsider.com

Strong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging Industry

April 26, 2024 | WealthPress (Ad)

$25,000 into $109,616 in two months?

April 18, 2024 | americanbankingnews.com

West Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday

April 18, 2024 | americanbankingnews.com

Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. Increased by Zacks Research (NYSE:WST)

April 17, 2024 | finance.yahoo.com

Here's Why We Think West Pharmaceutical Services, Inc.'s (NYSE:WST) CEO Compensation Looks Fair for the time being

April 17, 2024 | americanbankingnews.com

Zacks Research Research Analysts Lower Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)

April 15, 2024 | msn.com

West Pharmaceutical Services to Announce Q1 Results, Hosts Conference Call

April 11, 2024 | prnewswire.com

West to Host First-Quarter 2024 Conference Call

April 1, 2024 | finance.yahoo.com

What Makes West Pharmaceutical Services (WST) an Attractive Bet?

March 20, 2024 | finance.yahoo.com

WST Apr 2024 450.000 call

March 16, 2024 | wsj.com

West Pharmaceutical Services Inc.

March 16, 2024 | nasdaq.com

May 17th Options Now Available For West Pharmaceutical Services (WST)

March 16, 2024 | finance.yahoo.com

WST Apr 2024 300.000 put

March 14, 2024 | investorplace.com

3 Pharma Stocks to Sell in March Before They Crash & Burn

March 14, 2024 | msn.com

S&P 500 Gains and Losses Today: Index Slides After Uptick in Wholesale Inflation

March 12, 2024 | finance.yahoo.com

Insider Sell: VP, Chief Accounting Officer Chad Winters Sells Shares of West Pharmaceutical ...

March 12, 2024 | finance.yahoo.com

Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value

March 1, 2024 | finance.yahoo.com

West Pharmaceutical Services Inc President and CEO Eric Green Sells Company Shares

February 28, 2024 | seekingalpha.com

Why West Pharma Is Far From Done

February 27, 2024 | finance.yahoo.com

Insider Sell: SVP, Chief Technology Officer Silji Abraham Sells 7,012 Shares of West ...

See More Headlines

Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/7 Dividend: 1/30/2024
Dividend Payable: 2/07/2024
Last Earnings: 2/15/2024
Ex-Dividend for 5/1 Dividend: 4/23/2024
Today: 4/25/2024
Next Earnings (Confirmed): 4/25/2024
Dividend Payable: 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Current Symbol: NYSE:WST
CUSIP: 95530610
CIK: 105770
Web: www.westpharma.com
Phone: (610) 594-2900
Fax: 800-345-9800
Employees: 10,600
Year Founded: 1923

Price Target and Rating

Average Stock Price Target: $435.20
High Stock Price Target: $536.00
Low Stock Price Target: $375.00
Potential Upside/Downside: +16.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.80
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $7.88
Trailing P/E Ratio: 47.62
Forward P/E Ratio: 49.24
P/E Growth: 6.67
Net Income: $593.40 million
Net Margins: 20.12%
Pretax Margin: 23.66%
Return on Equity: 21.60%
Return on Assets: 16.26%

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 2.88
Quick Ratio: 2.24

Sales & Book Value

Annual Sales: $2.95 billion
Price / Sales: 9.31
Cash Flow: $9.79 per share
Price / Cash Flow: 38.33
Book Value: $39.31 per share
Price / Book: 9.55

Miscellaneous

Outstanding Shares: 73,210,000
Free Float: 72,817,000
Market Cap: $27.47 billion
Optionable: Optionable
Beta: 1.04

Social Links

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Eric M. Green (Age 54)
Non-Independent Chair of the Board, President & CEO
Comp: $2.9M
Mr. Bernard J. Birkett (Age 55)
Senior VP and Chief Financial & Operations Officer
Comp: $1.39M
Mr. Silji Abraham (Age 52)
Senior VP & CTO
Comp: $972.09k
Ms. Kimberly Banks MacKay (Age 58)
Senior VP, General Counsel & Company Secretary
Comp: $841.52k
Ms. Cindy Reiss-Clark (Age 50)
Senior VP & Chief Commercial Officer
Comp: $879.48k
Mr. Chad R. Winters (Age 45)
VP, Chief Accounting Officer & Corporate Controller
Dr. Quintin J. Lai C.F.A. (Age 57)
Ph.D., Vice President of Strategy & Investor Relations
Michele Polinsky
Vice President of Global Communications
Mr. Rudy Poussot
Senior VP of Strategy & Corporate Development
Ms. Annette F. Favorite (Age 59)
Chief Human Resources Officer & Senior VP
Comp: $803.25k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

WST Stock Analysis - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" WST shares.
View WST analyst ratings or view top-rated stocks.
What is West Pharmaceutical Services' stock price target for 2024?: 5 Wall Street analysts have issued 1 year price objectives for West Pharmaceutical Services' shares. Their WST share price targets range from $375.00 to $536.00. On average, they anticipate the company's share price to reach $435.20 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for WST or view top-rated stocks among Wall Street analysts.
How have WST shares performed in 2024?: West Pharmaceutical Services' stock was trading at $352.12 on January 1st, 2024. Since then, WST shares have increased by 4.6% and is now trading at $368.18.
View the best growth stocks for 2024 here.
How were West Pharmaceutical Services' earnings last quarter?: West Pharmaceutical Services, Inc. (NYSE:WST) posted its quarterly earnings data on Thursday, February, 15th. The medical instruments supplier reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.05. The medical instruments supplier earned $732 million during the quarter, compared to analyst estimates of $740.43 million. West Pharmaceutical Services had a net margin of 20.12% and a trailing twelve-month return on equity of 21.60%. West Pharmaceutical Services's revenue was up 3.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.77 earnings per share.
Read the conference call transcript.
How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?: West Pharmaceutical Services declared a quarterly dividend on Tuesday, February 20th. Shareholders of record on Wednesday, April 24th will be given a dividend of $0.20 per share on Wednesday, May 1st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.22%. The ex-dividend date is Tuesday, April 23rd.
Read our dividend analysis for WST.
Is West Pharmaceutical Services a good dividend stock?: West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.21%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 10.15%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 8.77% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.
What ETFs hold West Pharmaceutical Services' stock?: ETFs with the largest weight of West Pharmaceutical Services (NYSE:WST) stock in their portfolio include Subversive Mental Health ETF (SANE), Formidable Fortress ETF (KONG), VictoryShares THB Mid Cap ESG ETF (MDCP), Nuveen ESG Mid-Cap Growth ETF (NUMG), BlackRock Future Health ETF (BMED), Tema Cardiovascular and Metabolics ETF (HRTS), BlackRock Future Innovators ETF (BFTR) and Hilton Small-MidCap Opportunity ETF (SMCO).

What guidance has West Pharmaceutical Services issued on next quarter's earnings?: West Pharmaceutical Services issued an update on its FY 2024 earnings guidance on Thursday, April, 25th. The company provided EPS guidance of 7.630-7.880 for the period, compared to the consensus EPS estimate of 7.620. The company issued revenue guidance of $3.0 billion-$3.0 billion, compared to the consensus revenue estimate of $3.0 billion.
What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?: 107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.
What other stocks do shareholders of West Pharmaceutical Services own?: Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).
Who are West Pharmaceutical Services' major shareholders?: West Pharmaceutical Services' stock is owned by many different institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (4.50%), Congress Asset Management Co. MA (0.45%), Sumitomo Mitsui Trust Holdings Inc. (0.26%), AMI Asset Management Corp (0.23%), New York State Teachers Retirement System (0.11%) and Raymond James & Associates (0.10%). Insiders that own company stock include Annette F Favorite, Bernard Birkett, Chad Winters, Charles Witherspoon, Cindy Reiss-Clark, Eric Mark Green, Quintin J Lai, Silji Abraham and Thomas W Hofmann.
View institutional ownership trends.
How do I buy shares of West Pharmaceutical Services?: Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does West Pharmaceutical Services have any subsidiaries?: The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More

This page (NYSE:WST) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial